Hot Flashes
📧 Sign up to get email alerts when something new happens for Hot Flashes.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Veoza (fezolinetant) — Astellas Pharma Europe B.V.
Authorised European marketing approval for Veoza (fezolinetant) by Astellas Pharma Europe B.V. for menopause-related hot flashes.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007) [NA]
A feasibility study evaluating biometric measurements from wearable smartwatch technology to assess vasomotor symptoms in prostate cancer pa…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy [Phase 3]
This is a Phase 3 trial update evaluating fezolinetant for reducing hot flashes in women with breast cancer on hormone therapy; the study is…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Improving Sympathetic Activity, Hot Flashes, and Sleep in Midlife Women Using Inspiratory Muscle Strength Training [NA]
Mayo Clinic is recruiting midlife women for a study testing inspiratory muscle strength training to improve sympathetic activity, hot flashe…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause [Phase 2]
This update reports the completion of a Phase 2 trial evaluating fezolinetant for reducing hot flashes in Chinese women going through menopa…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Effect of High Power Laser Acupuncture on Post Menopausal Hot Flashes [NA]
A Cairo University-led clinical trial is investigating whether high power laser acupuncture can alleviate postmenopausal hot flashes; the st…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) [Phase 3]
Phase 3 trial update for elinzanetant in vasomotor symptoms associated with menopause; the OASIS-2 study has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause [Phase 3]
Phase 3 trial evaluating elinzanetant for vasomotor symptoms (hot flashes) due to menopause has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women [NA]
A completed clinical trial sponsored by Bonafide Health evaluated the effect of a herbal dietary supplement on vasomotor symptoms in menopau…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Effect of a Mindfulness-Based Stress Reduction Program on Hot Flashes and Sleep Quality in Menopausal Women: A Randomized Controlled Trial [NA]
A randomized controlled trial is evaluating whether a mindfulness-based stress reduction program improves hot flashes and sleep quality in m…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause [Phase 3]
Phase 3 study to evaluate the efficacy and safety of Elinzanetant for menopause-related vasomotor symptoms (hot flashes) over 52 weeks. Resu…
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: A Mobile App for Hot Flashes and Sleep Disturbances [NA]
A completed Baylor University–led clinical trial evaluated a mobile app aimed at reducing hot flashes and improving sleep disturbances.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause [Phase 2]
Phase 2 study of NOE-115 in women with vasomotor symptoms due to menopause has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: A Mind-Body Intervention for Hot Flash Management [NA]
A completed clinical trial evaluated a mind-body intervention for hot flashes and postmenopausal symptoms, with results posted on 2025-06-05…
-
CLINICAL_TRIALS research · 2025-06-03Clinical Trial Update: Hot Flashes and Neurovascular Function in Women [NA]
Mayo Clinic is recruiting participants for a clinical study examining hot flashes and neurovascular function during menopause.
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers [NA]
A clinical trial evaluating acupuncture with or without self-acupressure for post-oophorectomy hot flashes in BRCA mutation carriers is list…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: The Cardiovascular Impact of Hot Flushes
Clinical trial investigating the cardiovascular impact of hot flushes during menopause is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause [Phase 3]
Phase 3 study evaluating the safety and tolerability of fezolinetant for relief of vasomotor symptoms associated with menopause has complete…
-
CLINICAL_TRIALS research · 2025-01-22Clinical Trial Update: Strength and Aerobic Training Against Hot Flushes in Postmenopausal Women [NA]
A clinical trial from Linköping University is evaluating whether strength and aerobic exercise can reduce hot flashes in postmenopausal wome…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes [NA]
A completed clinical trial evaluating venlafaxine combined with hypnosis or focused attention for treating hot flashes in menopausal patient…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 2]
Phase 2 dose-finding study to identify the best dose of fezolinetant for treating hot flashes in menopausal women; the trial has completed.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Reflexology Versus Acupressure on Sleep Disturbance and Hot Flashes [NA]
A Cairo University-sponsored clinical trial compares reflexology versus acupressure for sleep disturbance and hot flashes in postmenopausal …
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating whether elinzanetant affects driving ability and brain function…
-
FDA approval · 2024-02-15FDA Approved: BIJUVA — Supplemental Application (Mayne Pharma)
The FDA approved a supplemental application for BIJUVA, a combination of estradiol and progesterone, submitted by Mayne Pharma. The approval…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health [Phase 2]
Phase 2 trial update for PhytoSERM addressing menopausal hot flashes and potential brain health implications.